From preclinical research to regulatory approval and clinical adoption, diagnostic testing underpins every stage of ADC ...

In mid-2024, the patient underwent a kidney transplant. Though he was relatively young for a transplant, that’s not where he ...

By Sharon AtienoThough more than 200 million people worldwide are affected by schistosomiasis (bilharzia), Africa bears the biggest brunt reporting nine out of ten cases globally. As such, a ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

The Rare Blood Donor Registry was launched at the National Conclave of Blood Transfusion Services in Kochi, attended by ...

Cell-cell interactions help drive tolerogenic or inflammatory responses to the maelstrom of antigens passing through the gut.

Introduction Therapeutic antibodies are laboratory-engineered proteins designed to replicate the immune system's natural ability to combat dise ...

Although B cells can recognize and respond to antigen in various forms, the current view is that membrane-bound antigens are the predominant forms that initiate B-cell activation in vivo.

George Washington died after his physician treated his sore throat with bloodletting, but don't let that stop you from ...

TScan Therapeutics is developing engineered T cell receptor therapies, with TSC-101 targeting HA-2 for acute leukemia. See ...

The growth of the vaccine technologies market is driven by rise in prevalence of infectious diseases, growing trend towards preventive healthcare, and government immunization programs and initiatives.

Epitopea, a transatlantic cancer immunotherapeutics company developing accessible off-the-shelf RNA-based immunotherapies, ...